Hara T, Tamai H, Mukuta T, Fukata S, Kuma K, Nakagawa T
Department of Psychosomatic Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Clin Endocrinol (Oxf). 1993 Nov;39(5):541-6. doi: 10.1111/j.1365-2265.1993.tb02406.x.
Although non-toxic diffuse goitre is a common disorder, little is known of the clinical course of patients. We therefore decided to investigate the long-term clinical outcome of patients with non-toxic diffuse goitre.
A retrospective study.
Of 850 patients with non-toxic diffuse goitre who met our criteria and were seen in our thyroid clinic between 1977 and 1985, 108 who had been followed for from 5 to 14 years (mean 8 years) were entered in this study. All patients fulfilled our criteria having soft diffuse goitres, normal serum TSH and T4 concentrations, and undetectable antithyroglobulin and antithyroid microsomal antibodies.
A family history of thyroid disease was obtained and the occurrence of Graves' ophthalmopathy was noted. Serum TSH and T4 concentrations, and antithyroglobulin and antithyroid microsomal antibodies were measured during the follow-up period. Thyroidal radioactive iodine uptake (RAIU), serum free T4 and free T3 concentrations, and TSH binding inhibitory immunoglobulin (TBII) activities were determined in all patients who were subsequently found to have abnormal serum TSH or T4 concentrations or signs of Graves' ophthalmopathy.
Thirty-six of the 108 patients (33%) had a family history of autoimmune thyroid disease. Elevated serum T4 or free T4 concentrations and depressed serum TSH concentrations were found in six patients during the follow-up period. Hyperthyroid Graves' disease was diagnosed in four of the six patients, subacute thyroiditis in one, and transient post-partum thyrotoxicosis in one. Hypothyroidism was found in one patient who was diagnosed as having transient post-partum hypothyroidism. Euthyroid Graves' disease was diagnosed in one patient. Furthermore, six of these eight patients had a family history of autoimmune thyroid disease in first-degree relatives.
During a prolonged follow-up period of patients with non-toxic diffuse goitre, Graves' disease was found in five of 108 patients (four hyperthyroid Graves' and one euthyroid Graves'), post-partum thyroid dysfunction in two, and subacute thyroiditis in one. Six of these eight patients had a family history of autoimmune thyroid disease in first-degree relatives. Long-term follow-up is necessary for patients with non-toxic diffuse goitre, especially those who have a family history of autoimmune thyroid disease.
尽管非毒性弥漫性甲状腺肿是一种常见疾病,但对患者的临床病程了解甚少。因此,我们决定调查非毒性弥漫性甲状腺肿患者的长期临床结局。
一项回顾性研究。
在1977年至1985年间,于我们甲状腺门诊就诊且符合我们标准的850例非毒性弥漫性甲状腺肿患者中,108例随访了5至14年(平均8年)并纳入本研究。所有患者均符合我们的标准,即具有柔软的弥漫性甲状腺肿、血清促甲状腺激素(TSH)和甲状腺素(T4)浓度正常、抗甲状腺球蛋白和抗甲状腺微粒体抗体检测不到。
获取甲状腺疾病家族史并记录格雷夫斯眼病的发生情况。在随访期间测量血清TSH和T4浓度、抗甲状腺球蛋白和抗甲状腺微粒体抗体。对所有随后发现血清TSH或T4浓度异常或有格雷夫斯眼病体征的患者,测定甲状腺放射性碘摄取(RAIU)、血清游离T4和游离T3浓度以及促甲状腺激素结合抑制性免疫球蛋白(TBII)活性。
108例患者中有36例(33%)有自身免疫性甲状腺疾病家族史。随访期间,6例患者血清T4或游离T4浓度升高,血清TSH浓度降低。6例患者中有4例被诊断为甲状腺功能亢进型格雷夫斯病,1例为亚急性甲状腺炎,1例为产后短暂甲状腺毒症。1例患者被诊断为产后短暂甲状腺功能减退症。1例患者被诊断为甲状腺功能正常型格雷夫斯病。此外,这8例患者中有6例在一级亲属中有自身免疫性甲状腺疾病家族史。
在对非毒性弥漫性甲状腺肿患者的长期随访期间,108例患者中有5例发生格雷夫斯病(4例甲状腺功能亢进型格雷夫斯病和1例甲状腺功能正常型格雷夫斯病),2例发生产后甲状腺功能障碍,1例发生亚急性甲状腺炎。这8例患者中有6例在一级亲属中有自身免疫性甲状腺疾病家族史。非毒性弥漫性甲状腺肿患者,尤其是有自身免疫性甲状腺疾病家族史的患者,有必要进行长期随访。